Related Experiment Video
Updated: Jul 26, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
[Mutagenicity studies of iodixanol, a new non-ionic isotonic contrast medium]
M Igarashi1, S Nakayama, E Jones
1Drug Research Center, Developmental Research Institute, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
Abstract:
A new non-ionic isotonic contrast medium, iodixanol (a diastereomeric mixture of 5,5'-[(2-hydroxytrimethylene) bis (acetylimino)] bis [N, N'-bis (2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzene-dicarboxamide]) was studied for mutagenicity by using the Ames method, in vitro cytogenetics and micronucleus test. Iodixanol had no mutagenic effect on S. typhimurium (TA1535, TA1537, TA1538, TA98 and TA100) or E. coli (WP2uvrA) in the reverse mutation assay with or without metabolic activations. In the cytogenetic study, iodixanol had no effect on the Chinese hamster cells with or without metabolic activations. Intravenous injections of iodixanol for two times at a dose of 800, 1,600 or 3,200 mgI/kg in the mouse micronucleus test did not increase the incidence of micronucleated polychromatic erythrocytes. These results show that iodixanol has no mutagenic potential.
More Related Videos
03:52Suspension Culture Production and Purification of Adeno-Associated Virus by Iodixanol Density Gradient Centrifugation for In Vivo Applications
Published on: February 9, 2024
08:00Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction
Published on: April 10, 2026
Related Concept Videos
In vitro Mutagenesis
Mutagenicity and Carcinogenicity
Redox Titration: Iodimetry and Iodometry
Ion Exchange
Radiological Investigation I: X-ray and CT
Imaging Studies III: Computed Tomography